Management changes at XOMA
This article was originally published in Scrip
Executive Summary
Steve Engle, XOMA's chief executive officer, president and chairman has resigned from the company after four years' service. John Varian, a current board member and former COO and CFO of Aryx Therapeutics, will take over as interim CEO during the search for a permanent CEO, and W Denman Van Ness, XOMA's lead independent director, has been elected chairman.